Cardiothoracic & vascular anesthesia

Impact of Restrictive Versus Liberal Oxygenation on Pulmonary Decline After Cardiac Surgery: A Substudy of the GLORIOUS Randomized Clinical Trial

J Cardiothorac Vasc AnesthPublished Secondary analysis of the GLORIOUS randomised trial

Authors' conclusion

While pulmonary function exhibited a mild-to-moderate decline 3 months after cardiac surgery, a restrictive (FiO2 50%) oxygenation strategy during CPB did not attenuate this decline compared with a liberal (FiO2 100%) strategy.

Study context

Population
Adults undergoing nonemergent coronary artery bypass grafting (CABG) and/or surgical aortic valve replacement, single tertiary center
Participants
878 adults
Comparison
Restrictive vs Liberal
Methodological detailspredefined, exploratory substudy, single-centre
  • Predefined
  • Exploratory substudy
  • Single-centre

Primary result

As reported in the abstract

Between-group difference in pulmonary function decline · 3 months
  • No significant between-group differences in decline (all p > 0.3), including in subgroup analyses

Further findings

Pulmonary function decline, overall study population · 3 months

Median FEV₁ (% predicted) decline, percentage points
8.3 (95% CI 6.6 to 8.3; p< 0.001)
FVC (% predicted) decline, percentage points
6.1 (95% CI 5.2 to 7.0; p< 0.001)
FEV₁/FVC decline, percentage points
1.6 (95% CI 1.0 to 2.1; p< 0.001)
Diffusion capacity of carbon monoxide (% predicted corrected) decline, percentage points
7.7 (95% CI 6.2 to 9.1; p< 0.001)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Impact of Restrictive Versus Liberal Oxygenation on Pulmonary Decline After Cardiac Surgery: A Substudy of the GLORIOUS Randomized Clinical Trial. J Cardiothorac Vasc Anesth. Published 14 April 2026. doi:10.1053/j.jvca.2026.04.013

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.